https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=Rotigotin 2026-04-06T21:28:48Z Versionsgeschichte dieser Seite in PlusPedia MediaWiki 1.43.3 https://ddn.pluspedia.org/w/index.php?title=Rotigotin&diff=836483&oldid=prev 2023-01-14T22:13:50Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 14. Januar 2023, 22:13 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[Datei:Rotigotin2023Jan14.jpg|thumb|]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Datei:Rotigotin2023Jan14.jpg|thumb|<ins style="font-weight: bold; text-decoration: none;">Die Aminotetralinstruktur von Rotigotin entspricht der von Dopamin, ist aber starrer&lt;ref&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871129/figure/Fig1/&lt;/ref&gt;</ins>]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>(–)-(S)-6-[Propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>(–)-(S)-6-[Propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol</div></td></tr> </table>

Penarc https://ddn.pluspedia.org/w/index.php?title=Rotigotin&diff=836482&oldid=prev 2023-01-14T22:10:25Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 14. Januar 2023, 22:10 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l17">Zeile 17:</td> <td colspan="2" class="diff-lineno">Zeile 17:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661406/ Binde CD, Tvete IF, Gåsemyr JI, Natvig B, Klemp M.] 2020 Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson&#039;s disease: a multiple treatment comparison meta-analysis. Eur J Clin Pharmacol. 76(12):1731-1743</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661406/ Binde CD, Tvete IF, Gåsemyr JI, Natvig B, Klemp M.] 2020 Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson&#039;s disease: a multiple treatment comparison meta-analysis. Eur J Clin Pharmacol. 76(12):1731-1743</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[Category:<del style="font-weight: bold; text-decoration: none;">Arznei</del>]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">==Quelle==</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[https://karmel.miraheze.org/w/index.php?title=Rotigotine&amp;oldid=22671 Rotigotine] karmel(es)</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Category:<ins style="font-weight: bold; text-decoration: none;">Arzneimittel</ins>]]</div></td></tr> </table>

Penarc https://ddn.pluspedia.org/w/index.php?title=Rotigotin&diff=836478&oldid=prev 2023-01-14T22:01:50Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 14. Januar 2023, 22:01 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Datei:Rotigotin2023Jan14.jpg|thumb|]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Datei:Rotigotin2023Jan14.jpg|thumb|]]</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">(–)-(S)-6-[Propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">==Weblinks==</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z. Diagnosis, treatment and management of apathy in Parkinson&#039;s disease: a scoping review. BMJ Open. 2020;10(9):e037632</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z. Diagnosis, treatment and management of apathy in Parkinson&#039;s disease: a scoping review. BMJ Open. 2020;10(9):e037632</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> </table>

Penarc https://ddn.pluspedia.org/w/index.php?title=Rotigotin&diff=836477&oldid=prev 2023-01-14T22:01:11Z

<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Rotigotin2023Jan14.jpg" title="Datei:Rotigotin2023Jan14.jpg">thumb|</a> Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z. Diagnosis, treatment and management of apathy in Pa…“</p> <p><b>Neue Seite</b></p><div>[[Datei:Rotigotin2023Jan14.jpg|thumb|]]<br /> Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z. Diagnosis, treatment and management of apathy in Parkinson&#039;s disease: a scoping review. BMJ Open. 2020;10(9):e037632<br /> <br /> [https://www.elsevier.es/es-revista-neurologia-295-pdf-S0213485311002246 Alonso Cánovas A, Luquin Piudo R, García Ruiz-Espiga P, Burguera JA, Campos Arillo V, Castro A, Linazasoro G, López Del Val J, Vela L, Martínez Castrillo JC]. Dopaminergic agonists in Parkinson&#039;s disease. Neurologia. 2014 May;29(4):230-41. English, Spanish<br /> <br /> Zhou CQ, Li SS, Chen ZM, Li FQ, Lei P, Peng GG. Rotigotine transdermal patch in Parkinson&#039;s disease: a systematic review and meta-analysis. PLoS One. 2013;8(7):e69738 doi:10.1371/journal.pone.0069738<br /> <br /> [https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/28567/21363 Chen F, Jin L, Nie Z.] Safety and Efficacy of Rotigotine for Treating Parkinson&#039;s Disease: A Meta-Analysis of Randomised Controlled Trials. J Pharm Pharm Sci. 2017;20(0):285-294 <br /> doi: 10.18433/J3Q35D. <br /> PMID: 28810946.<br /> <br /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585311/ Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR.] Rotigotine transdermal patch and sleep in Parkinson&#039;s disease: where are we now? NPJ Parkinsons Dis. 2017 Sep 5;3:28<br /> <br /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661406/ Binde CD, Tvete IF, Gåsemyr JI, Natvig B, Klemp M.] 2020 Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson&#039;s disease: a multiple treatment comparison meta-analysis. Eur J Clin Pharmacol. 76(12):1731-1743<br /> [[Category:Arznei]]</div>

Penarc